Amygdala and oxytocin functioning as keys to understanding and treating autism: 
Commentary on an RDoC based approach

Preckel, Katrin; Kanske, Philipp

doi:10.1016/j.neubiorev.2018.08.012

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Amygdala and oxytocin functioning as keys to understanding and treating autism: Commentary on an RDoC based approach

MPS-Authors

/persons/resource/persons141337

Preckel, Katrin
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19764

Kanske, Philipp
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;
Chair for Clinical Psychology and Behavioral Neuroscience, Faculty of Psychology, TU Dresden, Germany;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Preckel, K., & Kanske, P. (2018). Amygdala and oxytocin functioning as keys to understanding and treating autism: Commentary on an RDoC based approach. Neuroscience and Biobehavioral Reviews, 94, 45-48. doi:10.1016/j.neubiorev.2018.08.012.

引用: https://hdl.handle.net/21.11116/0000-0002-0065-C

要旨

The recent review by Hennessey, Andari and Rainnie (2018) utilizes the proposed Research Domain Criteria (RDoC) to classify amygdala functions and relate them to autism symptomatology. This approach has the potential to challenge the overarching autism diagnosis by furthering our knowledge of the mechanisms giving rise to autism psychopathology and generate novel treatment options. The purpose of this commentary is to provide additional information on a number of points raised in the review. Thus, (1) we discuss the issue of amygdala and brain overgrowth in children with autism and relate it to developmental oxytocin changes, (2) examine potential mechanisms that underlie amygdala overgrowth and dysfunction of the oxytocin system, (3) zoom in on the sexually dimorphic characteristics of the amygdala and potential parallels with the oxytocin system and (4) discuss how the interplay of oxytocin and vasopressin may explain the partially inconsistent findings of their effects on amygdala functioning.